No Data
No Data
No Data
No Data
No Data
Earnings Call Summary | Kymera Therapeutics(KYMR.US) Q1 2024 Earnings Conference
The following is a summary of the Kymera Therapeutics, Inc. (KYMR) Q1 2024 Earnings Call Transcript:Financial Performance:Kymera reported Q1 2024 revenue of $10.3 million, solely from its collaboratio
moomoo AIMay 3 16:22 ET · Conference Call
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
Yahoo FinanceMay 3 12:23 ET
Companies Like Kymera Therapeutics (NASDAQ:KYMR) Can Afford To Invest In Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com
Simply Wall StMay 3 09:34 ET
Kymera Therapeutics Is Maintained at Outperform by Oppenheimer
Kymera Therapeutics Is Maintained at Outperform by Oppenheimer
Dow JonesMay 3 09:19 ET
Oppenheimer Keeps Their Buy Rating on Kymera Therapeutics (KYMR)
TipRanksMay 3 08:07 ET
Express News | Kymera Therapeutics : Oppenheimer Cuts Target Price to $52 From $53
ReutersMay 3 08:06 ET
No Data
No Data